Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aloenin is a natural phenylpyrone glucoside primarily isolated from *Aloe* species, such as *Aloe arborescens*. It is being investigated for its therapeutic potential in treating inflammatory skin conditions, most notably psoriasis. The compound exhibits significant anti-inflammatory and antioxidant properties, which it exerts by reducing the levels of proinflammatory cytokines and mitigating oxidative stress. In experimental models, aloenin has been formulated into nanogels to enhance its topical delivery, demonstrating the ability to improve skin thickness, reduce erythema, and promote healing in imiquimod-induced psoriasis-like conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aloenin.